Researchers characterized the gut microbiota composition associated with the durability of COVID-19 vaccine-induced immunity.
I-Mab CEO details considerations behind China split, hints at potential in-licensing
I-Mab’s CEO is hoping its recent reorganization — splitting its US and China operations — will simplify its investment thesis by shifting the risk profile